Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Elixinol Wellness.
RELATED STOCKHEAD STORIES
Health & Biotech
Elixinol says it’s the first ASX cannabis stock to turn a profit
Health & Biotech
The US is already a monster cannabis market – and it’s not even legal there yet
IPO Watch
Miss out on another IPO? Here’s why retail investors get dudded in ASX floats
Health & Biotech
US Senate passes hemp law, opens door to legal cannabis market
Health & Biotech
Here’s how much money ASX cannabis stocks made last quarter
Health & Biotech
US law changes could open a monster cannabis market says Elixinol chief
Health & Biotech
Which ASX pot stocks hold those golden Aussie cannabis licences
Health & Biotech
Hemp play and ASX newbie Elixinol reports $16.5m revenue, $1.9m loss
News
Who got the cream in last week’s ASX small cap winners and losers list
IPO Watch
IPO Watch: Which ASX floats are looking hot and which are not
Health & Biotech
